View in EDS

In vitro inhibition of Escherichia coli β-glucuronidase by aripiprazole.

Saved in:
Bibliographic Details
Title: In vitro inhibition of Escherichia coli β-glucuronidase by aripiprazole.
Authors: Sugiyama K; Department of Legal Medicine, Graduate School of Medicine, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-0064, Japan., Sato K; Department of Sports and Health Sciences, Graduate School of Biomedical Engineering, Tohoku University, 6-6-12, Aramaki Aza Aoba-ku, Sendai, Miyagi, 980-8579, Japan. kensuke.sato.a7@tohoku.ac.jp.; Department of Adduct Biology and Gut Microbial Function, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo, 157-8577, Japan. kensuke.sato.a7@tohoku.ac.jp., Aoki H; Department of Adduct Biology and Gut Microbial Function, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo, 157-8577, Japan., Kotori M; Department of Adduct Biology and Gut Microbial Function, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo, 157-8577, Japan.; Department of Clinical Research and Development, Graduate School of Pharmacy, Showa Medical University, Tokyo, Japan., Nakano R; Department of Physiology, Graduate School of Pharmacy, Showa Medical University, Tokyo, Japan., Hida N; Department of Clinical Research and Development, Graduate School of Pharmacy, Showa Medical University, Tokyo, Japan., Kusano M; Department of Legal Medicine, Graduate School of Medicine, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-0064, Japan. maiko-k@med.showa-u.ac.jp., Akiyama M; Department of Adduct Biology and Gut Microbial Function, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo, 157-8577, Japan. akiyama.sw@med.showa-u.ac.jp.
Source: Pharmacological reports : PR [Pharmacol Rep] 2026 Jun 04. Date of Electronic Publication: 2026 Jun 04.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101234999 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2299-5684 (Electronic) Linking ISSN: 17341140 NLM ISO Abbreviation: Pharmacol Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42243593
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: In vitro inhibition of Escherichia coli β-glucuronidase by aripiprazole.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sugiyama+K%22">Sugiyama K</searchLink>; Department of Legal Medicine, Graduate School of Medicine, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-0064, Japan.<br /><searchLink fieldCode="AU" term="%22Sato+K%22">Sato K</searchLink>; Department of Sports and Health Sciences, Graduate School of Biomedical Engineering, Tohoku University, 6-6-12, Aramaki Aza Aoba-ku, Sendai, Miyagi, 980-8579, Japan. kensuke.sato.a7@tohoku.ac.jp.; Department of Adduct Biology and Gut Microbial Function, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo, 157-8577, Japan. kensuke.sato.a7@tohoku.ac.jp.<br /><searchLink fieldCode="AU" term="%22Aoki+H%22">Aoki H</searchLink>; Department of Adduct Biology and Gut Microbial Function, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo, 157-8577, Japan.<br /><searchLink fieldCode="AU" term="%22Kotori+M%22">Kotori M</searchLink>; Department of Adduct Biology and Gut Microbial Function, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo, 157-8577, Japan.; Department of Clinical Research and Development, Graduate School of Pharmacy, Showa Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Nakano+R%22">Nakano R</searchLink>; Department of Physiology, Graduate School of Pharmacy, Showa Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hida+N%22">Hida N</searchLink>; Department of Clinical Research and Development, Graduate School of Pharmacy, Showa Medical University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kusano+M%22">Kusano M</searchLink>; Department of Legal Medicine, Graduate School of Medicine, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-0064, Japan. maiko-k@med.showa-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Akiyama+M%22">Akiyama M</searchLink>; Department of Adduct Biology and Gut Microbial Function, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, 6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo, 157-8577, Japan. akiyama.sw@med.showa-u.ac.jp.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101234999%22">Pharmacological reports : PR</searchLink> [Pharmacol Rep] 2026 Jun 04. <i>Date of Electronic Publication: </i>2026 Jun 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International+Publishing%22">Springer International Publishing </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101234999 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2299-5684 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217341140%22">17341140 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacol Rep <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42243593
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s43440-026-00869-z
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: In vitro inhibition of Escherichia coli β-glucuronidase by aripiprazole.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sugiyama K
      – PersonEntity:
          Name:
            NameFull: Sato K
      – PersonEntity:
          Name:
            NameFull: Aoki H
      – PersonEntity:
          Name:
            NameFull: Kotori M
      – PersonEntity:
          Name:
            NameFull: Nakano R
      – PersonEntity:
          Name:
            NameFull: Hida N
      – PersonEntity:
          Name:
            NameFull: Kusano M
      – PersonEntity:
          Name:
            NameFull: Akiyama M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 06
              Text: 2026 Jun 04
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2299-5684
          Titles:
            – TitleFull: Pharmacological reports : PR
              Type: main
ResultId 1